Atom Investors LP Eliem Therapeutics, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.45 - $2.85 $1,494 - $1,738	-610 Reduced 0.77%	78,276 $211,000
Q1 2023 May 15, 2023	BUY	$2.3 - $4.64 $7,440 - $15,010	3,235 Added 4.28%	78,886 $228,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.69 $21,270 - $31,649	8,577 Added 12.79%	75,651 $277,000
Q3 2022 Nov 08, 2022	BUY	$2.72 - $3.97 $110,880 - $161,837	40,765 Added 154.95%	67,074 $217,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $8.4 $72,875 - $220,995	26,309 New	26,309 $79,000

53.1M

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.